Simon Dukes Pharmaceutical Services Negotiating Committee

Slides:



Advertisements
Similar presentations
Sheffield Local Pharmaceutical Committee Supporting Community Pharmacy NHS England’s Community Pharmacy Call to Action An Overview.
Advertisements

Croydon Clinical Commissioning Group An introduction.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
0 0 Bracknell and Ascot Clinical Commissioning Group Primary Care Transformation Jackie McGlynn CCG Clinical Director.
Preparing for 2018 – NHS priorities and pharmacy service development Sue Sharpe Chief Executive PSNC.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Nanette Kerr Chief Executive Officer Company Chemists’ Association A member.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Elizabeth Wade Director of Policy, Pharmacy Voice April 2016 Slide 1 of.
Psnc.org.uk/campaign #lovemypharmacy Community Pharmacy in 2016/17 and beyond The Community Pharmacy Review 2016/17.
Healthy Liverpool. Five areas of transformation “Not just physical activity, other factors have to be considered, loneliness, deprivation, housing conditions,
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
Community Pharmacy FORWARD VIEW Supported by the Royal Pharmaceutical Society English Pharmacy Board.
Primary Care Workforce Commission Aim: to identify models of primary care to meet the future needs of the NHS.
Setting the Scene Brian Montgomery Health Portfolio Director.
Health and Wellbeing VCS Forum
The NHS Urgent Medicine Supply Advance Service NUMSAS
Highly Preliminary Building a sustainable health and care system for the people of Sussex and East Surrey.
Integration, cooperation and partnerships
Sustainability and Transformation Partnership
The NHS Urgent Medicine Supply Advanced Service Pilot
Tracy Ellis Programme Delivery Lead
Our five year plan to improve local health and care services
Overview Service developments and the 17th Dec letter
South Yorkshire and Bassetlaw Sustainability and Transformation Plan
New care models: Setting the scene Jane McVea
Choice – 6 Steps, 6 Actions, 6 Weeks
Who we are We work for well run evidence based public care
General Practice Forward View (GPFV)
Think Pharmacy Sue Sharpe CEO PSNC.
Population healthcare
Worcestershire Joint Services Review
Nottinghamshire & Derbyshire GP / Pharmacy Transformation Programme Unlocking the Potential of Community Pharmacy Cathy Quinn Pharmacist Lead Newark &
How Community Pharmacy supports local communities in Brighton and Hove
Integrating Clinical Pharmacy into a wider health economy
Changes to the Community Pharmacy Contractual Framework in Wales
Further Information please contact:
in support of Primary Care Clusters :
Annual General Meeting
Sustainability and Transformation
Providing sustainable resilient primary care
Patient Engagement Group –Part 2 – Digital Transformation
in support of Primary Care Clusters :
Community Pharmacy: in support of Primary Care Clusters
Frimley Health and Care Integrated Care System
Specialised Commissioning Improving specialised services for severe intestinal failure adult patients What will this mean for you?
The Community Pharmacy Forward View Aug 2016
Technology Enabled Care and Support in Devon
A Summary of our Sustainability and Transformation Partnership (STP)
Sustainability & Transformation Plans (STP)
Our Vision / A look forward
General Practice: The future in rural areas
Simon Dukes PSNC Chief Executive
Promoting Wellbeing and Independence for Older People
Developing a Sustainability and Transformation Plan
Integrated Care System (ICS) Berkshire West
Worcestershire Joint Services Review
Our population is growing and most of us are living longer
Care Closer to Home Working with the voluntary sector
Self Care in Glossop.
Moving Forward Together Programme Overview
Primary Care Networks March 2019 Essex LMCs.
Salford Integrated Care Programme
Changes to the Community Pharmacy Contractual Framework in Wales
City Wide Update Event.
NHS LONG TERM PLAN.
Primary care networks and Social Prescribing – a national perspective
Community Pharmacy: your local healthcare team
SW HFMA conference 27th September 2019
Community pharmacy and Primary Care Networks – what you need to know This presentation provides a brief summary on Primary Care Networks (PCNs) and the.
Presentation transcript:

Simon Dukes Pharmaceutical Services Negotiating Committee The Future of Community Pharmacy: How pharmacies fit into the NHS Long Term Plan Simon Dukes Pharmaceutical Services Negotiating Committee

The Future of Community Pharmacy Pharmacies in England A five-year deal for pharmacy New services: CPCS and Hepatitis C Supporting our NHS colleagues Working within Primary Care Networks

Community Pharmacy: Key statistics 11,600 pharmacies in England - Independents (1-5 pharmacies) 38% - Multiples (6+ pharmacies) 62% 89% of the population can reach their local community pharmacy within a 20 minute walk An estimated 1.6 million visits to pharmacies take place daily

Community Pharmacy: Key statistics Over 90% of pharmacies now have a private consultation room Community pharmacies are accessed by people who may not access other NHS services, helping to reduce health inequalities NHS income for a typical community pharmacy accounts for 85% of their total turnover

The five-year CPCF agreement PSNC negotiates with DHSC and NHS E&I Deal fixes funding at £2.592bn per year from 2019/20 through to 2023/24 Sets out the expansion of clinical service delivery through pharmacies, in line with the aims of the NHS Long Term Plan

Ambitions of the five-year agreement Pharmacies will adapt to provide new services The settlement will: “Expand and transform the role of community pharmacies and embed them as the first port of call for minor illness and health advice in England.” Matt Hancock, Secretary of State

Negotiations: Political Context This was not the deal pharmacy wanted We argued for further investment Highlighted rising costs, threats to viability and the impact of cost-saving tactics The deal secures future funding for as long as possible from Treasury, who are seeking efficiencies in dispensing We believe it was the best deal available This was not the deal that PSNC wanted – we pushed hard for further investment in the sector. But we were unable to extract more money from Treasury, who see us as an expensive way for them to get medicines to patients. We outlined how rising costs were already threatening the viability of many community pharmacies warning that cost-saving tactics would reduce capacity to deliver the new services. The Government is not interested in covering pharmacy contractors’ costs; it wants to commission cost-effective services, including a significantly more efficient dispensing service. We believe Government no longer wants to pay for 11,600 community pharmacies: they believe there are too many pharmacies not utilising technology to the full.

What does this mean for pharmacies? The deal guarantees a future for those pharmacies who are up for change Specific challenges will be around: dispensing efficiencies  freeing up pharmacists’ time wider use of clinical workforce branch viability and consolidations coming together locally in PCNs working closer with GPs The deal guarantees the sector a future – not one that will be easy to attain, but one that does present opportunities for those who are willing to engage with it and to change. What that change might look like is something that all businesses will need to think about. It will mean looking at the dispensing process and seeing how this can be made more efficient to free up pharmacists’ time to focus on clinical services. For large businesses it will mean some difficult decisions about the viability of some branches. For independent contractors, particularly those in clusters of pharmacies, it will mean some incredibly difficult conversations with other local pharmacy businesses to work through how you can deliver what the Government wants either working in partnership, or even through consolidating your businesses. For everyone it will mean looking at your businesses and stopping doing the things you are not paid for. And no matter the size of your business, it will mean coming together with other pharmacy businesses locally to ensure that you are all a part of the emerging PCNs.

Two new national services in 2019/20 The Community Pharmacist Consultation Service (CPCS) Hepatitis C testing service Capacity being released through the decommissioning of MURs (replaced by structured clinical medication reviews) Hepatitis C testing will be available to people using pharmacy needle and syringe programmes. This service supports the Government’s new national Hepatitis C elimination programme

Supporting NHS Colleagues: The Community Pharmacist Consultation Service (CPCS) Helping people with minor illnesses and those needing urgent supplies of medicine Pharmacist will provide healthcare advice or assess whether an emergency supply of medicine is appropriate Onward referrals will be made if needed GPs to be notified electronically

Supporting NHS Colleagues: The CPCS Referrals initially to come from NHS 111 Pilots to test expansion with referrals from GP practices (reception teams) Increasing patient awareness of pharmacy as the ‘first port of call’ for minor illness Reducing pressure on practices and urgent care providers Supporting patients to self-manage their health

Driving pharmacy clinical service development Through the five-year deal, a range of pharmacy services will be piloted If successful, these may be commissioned nationally in future years The Pharmacy Integration Fund and the PCN Testbed programme are NHS development initiatives that will be used to provide the necessary funding for pilots

Reimbursement Changes and Consultation PSNC, BMA and DDA worked on shared principles Our response is principle-based: - Base prices on suppliers we purchase from - Remove dispensing at a loss - Fair distribution of margin - Certainty of reimbursement prior to dispensing - Smooth transition to new systems - Preventing any patient safety risks Time to revisit generic substitution

Conclusions Pharmacy’s new deal does much to integrate us with general practice Supporting medicines safety, optimisation and prevention CPCS: a new chance for us to help Collaboration will be key – both at PCN and individual practice level

Contact Information psnc.org.uk cpcf@psnc.org.uk 0203 1220 810